中国刚当众表态不允许！话音刚落，印度传来不同声音，事不简单

Group 1 - China firmly opposes any trade agreements that sacrifice its interests and will take reciprocal measures if necessary, emphasizing the importance of fair and just international trade rules [1] - The U.S. has announced a 10% baseline tariff on all trade partners, effective April 5, and higher tariffs on countries with significant trade deficits, impacting 185 countries and regions [1] - India is particularly affected, with an estimated 87% of its exports to the U.S. facing tariff increases, potentially leading to a $7.3 billion decline in exports for the fiscal year 2025-2026 [3] Group 2 - The U.S. plans to impose tariffs on pharmaceuticals, which are crucial for India, as 31% of its $27.9 billion pharmaceutical exports go to the U.S., raising concerns about the viability of Indian generic drug companies [3] - India has announced a temporary 12% tariff on certain steel imports to protect domestic manufacturers from increased competition, effective for 200 days [5] - India is actively negotiating with the U.S. for a bilateral trade agreement, with a potential "win-win" deal expected within 90 days, which may include provisions that could harm Chinese interests [7]